ABT

Abbott  (NYSE: ABT) Q2 2022 earnings call dated Jul. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and…

Abbott Laboratories (NYSE: ABT) reported second quarter 2022 earnings results. Total sales increased 10.1% year-over-year to $11.3 billion. On an…

Abbott (NYSE: ABT) Q2 2022 Earnings Conference

Like most healthcare-related businesses, Abbott Laboratories (NYSE: ABT) has been operating near full capacity for quite some time, with its…

Abbott Laboratories (NYSE: ABT) Q1 2022 earnings call dated Apr. 20, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations Robert…

Abbott (NYSE: ABT) today reported its first-quarter financial results for the period ended March 31, 2022. GAAP net earnings for…

Abbott Laboratories (NYSE: ABT) Q1 2022 Earnings Conference

Abbott Laboratories (NYSE: ABT) Q4 2021 earnings call dated Jan. 26, 2022 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing…

Abbott Laboratories (NYSE: ABT) Q4 2021 Earnings Conference

Abbott Laboratories (NYSE: ABT) Q4 2021 Earnings Conference